FACTOR EFFECTS ON ORAL COMPLICATIONS OF DIABETES

对糖尿病口腔并发症的影响因素

基本信息

  • 批准号:
    6379945
  • 负责人:
  • 金额:
    $ 22.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-30 至 2003-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: The salivary glands are a major source of several factors, which play important roles in both oral and systemic organ homeostasis and wound healing. The roles of these factors, which include IGF-I, IGF-II, NGF, TGF alpha and beta, and EGF, has been well-studied. However, the fact that the salivary glands appear to be a major source of these growth factors present a interesting question both in the primary route of reentry into the system and the relative importance of these salivary- derived proteins systemically. In diabetic patients both (Type I and II) a major disease complication is diminished capacity of wound healing and in the oral cavity increased periodontal disease. A similar picture occurs in animal models of diabetes in there is also a progressive loss of growth factors from saliva in accordance with diabetes onset. Therefore, the investigators propose to look for the potential loss of salivary-derived growth factors associated with the observed decrease in wound healing capacity in diabetic patients. To accomplish this goal, they first plan to use the diabetic patient base of the University of Florida to investigate the changes in growth factor levels in patient saliva and serum after surgical procedures, as compared to healthy non-diabetic individuals undergoing similar procedures. Second, they intend to determine the influence of changes in growth factor levels in saliva on wound healing in the NOD mouse model for IDDM. With this, they intend to establish the NOD mouse as a viable model for this aspect of the disease and then to be able to employ this model to more thoroughly investigate the impact of decreased levels of salivary growth factors on experimentally introduced soft and hard tissue injuries. The results of these studies should elucidate the importance of salivary-derived growth factors on systemic homeostasis and wound repair and potentially provide insight into the viability of replacement strategies to combat several complications of human diabetes which may involve an underlying deficiency in wound repair mechanisms.
描述:唾液腺是几种因子的主要来源, 它们在口腔和全身器官的动态平衡和 伤口愈合。这些因素的作用,包括IGF-I,IGF-II, NGF、转化生长因子α、β转化生长因子和表皮生长因子已经得到了很好的研究。然而,事实是 唾液腺似乎是这些生长的主要来源 因素提出了一个有趣的问题,这两个主要途径 以及这些唾液的相对重要性- 系统地衍生蛋白质。糖尿病患者(I型和II型) 一种主要的疾病并发症是伤口愈合能力减弱和 在口腔中增加了牙周病。类似的情况也发生了 在糖尿病的动物模型中,还有一种渐进性的生长丧失 来自唾液的因素与糖尿病的发病有关。因此, 研究人员建议寻找唾液来源的潜在损失 与观察到的伤口愈合率下降有关的生长因子 糖尿病患者的能力。为了实现这一目标,他们首先计划 利用佛罗里达大学的糖尿病患者基础进行调查 治疗前后患者唾液和血清中生长因子水平的变化 与健康的非糖尿病人相比,外科手术 正在经历类似的程序。其次,他们打算确定 唾液中生长因子水平的变化对创面愈合的影响 IDDM的点头鼠模型。有了这一点,他们打算建立点头 小鼠作为这方面疾病的可行模型,然后能够 要使用此模型来更彻底地调查 实验引入的唾液生长因子水平降低 软硬组织损伤。这些研究的结果应该是 阐明唾液源生长因子在系统性红斑狼疮中的重要性 动态平衡和伤口修复,并潜在地提供了对 替代战略的可行性,以对抗几种并发症 人类糖尿病,可能涉及伤口修复的潜在缺陷 机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL G HUMPHREYS-BEHER其他文献

MICHAEL G HUMPHREYS-BEHER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL G HUMPHREYS-BEHER', 18)}}的其他基金

Exocrine Gland Targeting in Autoimmune NOD Mice
自身免疫 NOD 小鼠的外分泌腺靶向
  • 批准号:
    6399816
  • 财政年份:
    2001
  • 资助金额:
    $ 22.15万
  • 项目类别:
M3 RECEPTOR: DIAGNOSTIC MARKER FOR SJOGREN'S SYNDROME
M3 受体:干燥综合征的诊断标志物
  • 批准号:
    6135024
  • 财政年份:
    2000
  • 资助金额:
    $ 22.15万
  • 项目类别:
FACTOR EFFECTS ON ORAL COMPLICATIONS OF DIABETES
对糖尿病口腔并发症的影响因素
  • 批准号:
    2897250
  • 财政年份:
    1998
  • 资助金额:
    $ 22.15万
  • 项目类别:
FACTOR EFFECTS ON ORAL COMPLICATIONS OF DIABETES
对糖尿病口腔并发症的影响因素
  • 批准号:
    6175913
  • 财政年份:
    1998
  • 资助金额:
    $ 22.15万
  • 项目类别:
FACTOR EFFECTS ON ORAL COMPLICATIONS OF DIABETES
对糖尿病口腔并发症的影响因素
  • 批准号:
    2761275
  • 财政年份:
    1998
  • 资助金额:
    $ 22.15万
  • 项目类别:
FACTOR EFFECTS ON ORAL COMPLICATIONS OF DIABETES
对糖尿病口腔并发症的影响因素
  • 批准号:
    6479889
  • 财政年份:
    1998
  • 资助金额:
    $ 22.15万
  • 项目类别:
Microarray Analysis-Intracellular Infection/Autoimmunty
微阵列分析-细胞内感染/自身免疫
  • 批准号:
    6314829
  • 财政年份:
    1998
  • 资助金额:
    $ 22.15万
  • 项目类别:
REGULATION OF ACINAR CELL PROLIFERATION
腺泡细胞增殖的调节
  • 批准号:
    2713268
  • 财政年份:
    1997
  • 资助金额:
    $ 22.15万
  • 项目类别:
REGULATION OF ACINAR CELL PROLIFERATION
腺泡细胞增殖的调节
  • 批准号:
    2897005
  • 财政年份:
    1997
  • 资助金额:
    $ 22.15万
  • 项目类别:
REGULATION OF ACINAR CELL PROLIFERATION
腺泡细胞增殖的调节
  • 批准号:
    2389418
  • 财政年份:
    1997
  • 资助金额:
    $ 22.15万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.15万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 22.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了